Arlington VA 卵巢癌临床试验
46项针对 卵巢癌的研究正在 Arlington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中欢迎健康志愿者
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
- Inova Fair Oaks Hospital, Fairfax · 距离 11 英里
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
招募中2 期
- Inova Fairfax Hospital, Falls Church · 距离 4 英里
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
招募中1/2 期
- Research Site, Fairfax · 距离 11 英里
A Study of PHST001 in Advanced Solid Tumors
招募中1 期
- NEXT Oncology - Virginia, Fairfax · 距离 11 英里
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
- NEXT Virginia, Fairfax · 距离 11 英里
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
招募中2 期
- Next Virginia /ID# 279684, Fairfax · 距离 11 英里
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
招募中1 期
- Site 04, Fairfax · 距离 11 英里
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
招募中1 期
- Next Virginia /ID# 278607, Fairfax · 距离 11 英里
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
招募中2 期
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · 距离 11 英里
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
招募中2 期
- Site 0322 - Inova Schar Cancer Institute, Fairfax · 距离 11 英里
Study of AVZO-021 in Patients With Advanced Solid Tumors
招募中1/2 期
- Avenzo Therapeutics Recruiting Site, Fairfax · 距离 11 英里
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
招募中3 期
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · 距离 11 英里
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
招募中1/2 期
- NEXT Oncology, Fairfax · 距离 11 英里
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
招募中3 期
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
招募中2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
招募中1/2 期
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
- Next Oncology Virginia, Fairfax · 距离 11 英里
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
招募中1 期
- NEXT Oncology, Fairfax · 距离 11 英里
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
招募中3 期
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · 距离 11 英里
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
招募中1 期
- Inova Schar Cancer Institute, Falls Church · 距离 4 英里
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
招募中1 期
- Normunity Investigational Site, Fairfax · 距离 11 英里
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
招募中
- Inova Fairfax Hospital, Falls Church · 距离 4 英里
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
- Inova Fair Oaks Hospital, Fairfax · 距离 11 英里
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
招募中1/2 期
- Clinical Trial Site, Fairfax · 距离 11 英里
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 距离 11 英里
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- USOR Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
招募中2 期
- 522, Fairfax · 距离 11 英里
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- USO-Virginia Cancer Specialists, PC, Fairfax · 距离 11 英里
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- NEXT, Fairfax · 距离 11 英里
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
招募中3 期
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
招募中1 期
- NEXT Oncology, Fairfax · 距离 11 英里
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
招募中1 期
- Dren Investigational Site, Fairfax · 距离 11 英里
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
招募中1 期
- Next Oncology, Virginia Cancer Specialists, Fairfax · 距离 11 英里
其他城市的 卵巢癌试验
- Houston, TX89 项研究
- New York City, NY69 项研究
- Boston, MA61 项研究
- Los Angeles, CA50 项研究
- Nashville, TN49 项研究
- Philadelphia, PA44 项研究
- Columbus, OH39 项研究
- St. Louis, MO38 项研究
- Chicago, IL36 项研究
- San Antonio, TX31 项研究
- Cleveland, OH30 项研究
- Pittsburgh, PA30 项研究
Arlington的其他研究
- 非小细胞肺癌104 项研究
- 转移性癌症53 项研究
- 结直肠癌52 项研究
- 癌症（所有类型）48 项研究
- 乳腺癌47 项研究
- 肺癌41 项研究
- 子宫内膜癌39 项研究
- 胰腺癌33 项研究
- 头颈鳞状细胞癌26 项研究
- 小细胞肺癌23 项研究
- 胃癌20 项研究
- 三阴性乳腺癌20 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。